Cargando…
Use of Procalcitonin during the First Wave of COVID-19 in the Acute NHS Hospitals: A Retrospective Observational Study
A minority of patients presenting to hospital with COVID-19 have bacterial co-infection. Procalcitonin testing may help identify patients for whom antibiotics should be prescribed or withheld. This study describes the use of procalcitonin in English and Welsh hospitals during the first wave of the C...
Autores principales: | Powell, Neil, Howard, Philip, Llewelyn, Martin J., Szakmany, Tamas, Albur, Mahableswhar, Bond, Stuart E, Euden, Joanne, Brookes-Howell, Lucy, Dark, Paul, Hellyer, Thomas P, Hopkins, Susan, McCullagh, Iain J, Ogden, Margaret, Pallmann, Philip, Parsons, Helena, Partridge, David G, Shaw, Dominick E., Shinkins, Bethany, Todd, Stacy, Thomas-Jones, Emma, West, Robert, Carrol, Enitan D, Sandoe, Jonathan A. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147337/ https://www.ncbi.nlm.nih.gov/pubmed/34062898 http://dx.doi.org/10.3390/antibiotics10050516 |
Ejemplares similares
-
P14 Procalcitonin evaluation of antibiotic use in COVID-19 hospitalized patients during the first wave of COVID-19: the PEACH study
por: Euden, Joanne, et al.
Publicado: (2022) -
Procalcitonin Evaluation of Antibiotic Use in COVID-19 Hospitalised Patients (PEACH): Protocol for a Retrospective Observational Study
por: Euden, Joanne, et al.
Publicado: (2022) -
Impact of introducing procalcitonin testing on antibiotic usage in acute NHS hospitals during the first wave of COVID-19 in the UK: a controlled interrupted time series analysis of organization-level data—authors’ response
por: Llewelyn, Martin J, et al.
Publicado: (2022) -
PROcalcitonin and NEWS2 evaluation for Timely identification of sepsis and Optimal use of antibiotics in the emergency department (PRONTO): protocol for a multicentre, open-label, randomised controlled trial
por: Euden, Joanne, et al.
Publicado: (2022) -
Procalcitonin Increase Is Associated with the Development of Critical Care-Acquired Infections in COVID-19 ARDS
por: Richards, Owen, et al.
Publicado: (2021)